New Key Statistics Module, Z-Score and F-Score
SZSE:002864 Key Ratios
Market Cap ¥ M | 3,194.81 |
Enterprise Value ¥ M | 2,193.15 |
P/E(ttm) | 28.09 |
PE Ratio without NRI | 27.25 |
Forward PE Ratio | -- |
Price/Book | 1.99 |
Price/Sales | 3.35 |
Price/Free Cash Flow | 42.36 |
Price/Owner Earnings | 51.30 |
Payout Ratio % | 0.20 |
Revenue (TTM) ¥ M | 981.00 |
EPS (TTM) ¥ | 1.07 |
Beneish M-Score | -2.63 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 12.70 |
y-y EBITDA Growth Rate % | -11.30 |
EV-to-EBIT | 16.03 |
EV-to-EBITDA | 16.03 |
PEG | 2.15 |
Shares Outstanding M | 106.28 |
Net Margin (%) | 11.81 |
Operating Margin % | 11.87 |
Pre-tax Margin (%) | 13.57 |
Quick Ratio | 3.73 |
Current Ratio | 3.92 |
ROA % (ttm) | 5.32 |
ROE % (ttm) | 7.39 |
ROIC % (ttm) | 15.53 |
Dividend Yield % | 0.73 |
Altman Z-Score | 4.67 |
SZSE:002864 Number of Guru Trades
SZSE:002864 Volume of Guru Trades
Gurus Latest Trades with SZSE:002864
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002864 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shaanxi Panlong Pharmaceutical Group Ltd Insider Transactions
No Available Data